Composition
- Active ingredients
- RANITIDINE HYDROCHLORIDE EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- RANITIDINE HYDROCHLORIDE EQ 150MG BASE · TabletNDA021698-002 · Discontinued
- RANITIDINE HYDROCHLORIDE EQ 150MG BASE · TabletNDA021698-001 · Discontinued
- RANITIDINE HYDROCHLORIDE EQ 150MG BASE · Tablet, effervescentNDA020251-001 · Discontinued
- RANITIDINE HYDROCHLORIDE EQ 150MG BASE/PACKET · Granule, effervescentNDA020251-002 · Discontinued
- RANITIDINE HYDROCHLORIDE EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA018703-001 · Discontinued
- RANITIDINE HYDROCHLORIDE EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA020095.
At a glance
- Brand name
- Zantac 150
- Active substance
- ranitidine hydrochloride
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Glaxosmithkline
- Status
- Discontinued
- FDA approval
- 8 Mar 1994
- Application
- NDA020095-001